AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Ceryvyn Therapeutics Limited

$0.01 -$0.43 (-97.73%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$0.01
Day Range
$0.01$0.29
Year Range
$0.01$0.44
Market Cap
13.68M
AVG Volume
649
Trailing/Forward PE
-/-
PEG ratio
-
Dividend Yield
-
Next Earnings Date
2027-02-23
Primary Exchange
Other OTCUS
Revenue (USD)
050K100K150K22 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q226 Q4
CKDXF Revenue (USD) by quarter
PeriodRevenue (USD)
26 Q40
26 Q2667
25 Q42.54K
25 Q223.96K
24 Q464.69K
24 Q293.18K
23 Q483.34K
23 Q277.79K
22 Q466.1K
22 Q2124.69K
Net Income (USD)
-200M-100M0100M200M300M22 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q226 Q4
CKDXF Net Income (USD) by quarter
PeriodNet Income (USD)
26 Q4-6.54M
26 Q2226.8M
25 Q4-32M
25 Q2-123.47M
24 Q4-125.65M
24 Q2-147.42M
23 Q4-96.84M
23 Q2-115.11M
22 Q4-79.81M
22 Q2-51.55M
Operating Income (USD)
-150M-100M-50M022 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q226 Q4
CKDXF Operating Income (USD) by quarter
PeriodOperating Income (USD)
26 Q4-3.38M
26 Q2-4.71M
25 Q4-73.23M
25 Q2-82.53M
24 Q4-99.36M
24 Q2-143.88M
23 Q4-105.61M
23 Q2-117.88M
22 Q4-79.4M
22 Q2-53.87M
EBITDA (USD)
-150M-100M-50M022 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q226 Q4
CKDXF EBITDA (USD) by quarter
PeriodEBITDA (USD)
26 Q4-3.38M
26 Q2-4.71M
25 Q4-7.84M
25 Q2-108.3M
24 Q4-110.01M
24 Q2-138.97M
23 Q4-106.86M
23 Q2-115.75M
22 Q4-82.83M
22 Q2-53.87M
Cash Flows (USD)
-150M-100M-50M021 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
CKDXF Cash Flows (USD) by quarter
PeriodCash Flows (USD)
26 Q2-6.61M
25 Q4-92.26M
25 Q2-31.38M
24 Q4-92.25M
24 Q2-106.31M
23 Q4-75.11M
23 Q2-103.45M
22 Q4-61.7M
22 Q2-39.31M
21 Q4-27.08M
EPS (USD)
-0.4-0.200.222 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q226 Q4
CKDXF EPS (USD) by quarter
PeriodEPS (USD)
26 Q4-0
26 Q20.17
25 Q4-0.03
25 Q2-0.19
24 Q4-0.19
24 Q2-0.25
23 Q4-0.2
23 Q2-0.23
22 Q4-0.23
22 Q2-0.14
Expenses (USD)
050M100M150MR&DSG&ACapex22 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q226 Q4
CKDXF Expenses (USD) by quarter
PeriodExpenses (USD)
21 Q45.42K
26 Q43.38M
26 Q24.71M
25 Q473.23M
25 Q279.8M
24 Q499.4M
24 Q2143.9M
23 Q4105.66M
23 Q2117.96M
22 Q456.73M
22 Q254M
Cash & Debt (USD)
0100M200M300MCashLong Term DebtShort Term Debt22 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q226 Q4
CKDXF Cash & Debt (USD) by quarter
PeriodCash & Debt (USD)
26 Q420.77M
26 Q222.13M
25 Q448.61M
25 Q2131.81M
24 Q4172.47M
24 Q2157.07M
23 Q4133.99M
23 Q2209.06M
22 Q444.63M
22 Q2121.41M
Debt ratios
-1-0.500.511.522 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q226 Q4
CKDXF Debt ratios by quarter
PeriodDebt ratios
26 Q40.17
26 Q20.1
25 Q4-0.55
25 Q2-0.2
24 Q40.07
24 Q20.35
23 Q40.37
23 Q20.44
22 Q40.25
22 Q21.1
Margins
-200%0%200%400%600%800%21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
CKDXF Margins by quarter
PeriodMargins
26 Q20%
25 Q4-117.65%
25 Q2621.78%
24 Q418.77%
24 Q215.88%
23 Q4-53.5%
23 Q2-54.12%
22 Q4-170.97%
22 Q2100%
21 Q4321.62%
Return on Capital
-500%0%500%1000%1500%22 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q226 Q4
CKDXF Return on Capital by quarter
PeriodReturn on Capital
26 Q4-31.94%
26 Q21008.05%
25 Q415.86%
25 Q273.24%
24 Q4165.74%
24 Q2314.23%
23 Q41101.33%
23 Q2-138.24%
22 Q4-166.36%
22 Q2-37.38%
Shares Outstanding
0500M1B1.5B22 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q226 Q4
CKDXF Shares Outstanding by quarter
PeriodShares Outstanding
26 Q41.37B
26 Q21.33B
25 Q41.23B
25 Q2638.2M
24 Q4678.66M
24 Q2592.64M
23 Q4495.57M
23 Q2495.31M
22 Q4351.98M
22 Q2372.5M
Book Value Per Share (USD)
-0.4-0.200.20.422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q226 Q4
CKDXF Book Value Per Share (USD) by quarter
PeriodBook Value Per Share (USD)
26 Q40.01
26 Q20.02
25 Q4-0.16
25 Q2-0.26
24 Q4-0.11
24 Q2-0.08
23 Q4-0.02
23 Q20.17
22 Q40.14
22 Q20.37
Total Assets (USD)
0100M200M300M22 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q226 Q4
CKDXF Total Assets (USD) by quarter
PeriodTotal Assets (USD)
26 Q422.09M
26 Q223.71M
25 Q456.99M
25 Q2145.66M
24 Q4188.79M
24 Q2166.5M
23 Q4148.19M
23 Q2227.1M
22 Q460.05M
22 Q2150.22M
Employee Count
01020304020212022202320242025
CKDXF Employee Count by quarter
PeriodEmployee Count
202510
202434
202324
202218
20219
Free Cash Flow Yield
-2000%-1500%-1000%-500%0%med -108.63%Sep 24Jan 25Jul 25Oct 25Feb 26May 26Sep 26
CKDXF Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-1670.56%
Sep 26-1670.56%
Aug 26-1670.56%
Aug 26-1670.56%
Aug 26-1670.56%
Aug 26-1670.56%
Jul 26-1670.56%
Jul 26-1670.56%
Jul 26-1670.56%
Jul 26-1670.56%
Jul 26-1670.56%
Jun 26-1670.56%
Jun 26-1670.56%
Jun 26-1670.56%
Jun 26-37.97%
May 26-37.97%
May 26-37.97%
May 26-37.97%
May 26-37.97%
May 26-37.97%
Apr 26-37.97%
Apr 26-37.97%
Apr 26-37.97%
Apr 26-37.97%
Mar 26-59.47%
Mar 26-59.47%
Mar 26-59.47%
Mar 26-59.47%
Feb 26-59.47%
Feb 26-59.47%
Feb 26-59.47%
Feb 26-59.47%
Jan 26-59.47%
Jan 26-59.47%
Jan 26-59.47%
Jan 26-59.47%
Jan 26-59.47%
Dec 25-59.47%
Dec 25-59.47%
Dec 25-59.47%
Dec 25-59.47%
Nov 25-59.47%
Nov 25-59.47%
Nov 25-59.47%
Nov 25-59.47%
Oct 25-59.47%
Oct 25-59.47%
Oct 25-59.47%
Oct 25-59.47%
Oct 25-59.47%
Sep 25-108.63%
Sep 25-108.63%
Sep 25-108.63%
Sep 25-108.63%
Aug 25-108.63%
Aug 25-108.63%
Aug 25-108.63%
Aug 25-108.63%
Aug 25-108.63%
Jul 25-108.63%
Jul 25-108.63%
Jul 25-108.63%
Jul 25-108.63%
Jun 25-108.63%
Jun 25-108.63%
Jun 25-108.63%
Jun 25-108.63%
May 25-108.63%
May 25-108.63%
Feb 25-126.29%
Feb 25-126.29%
Feb 25-126.29%
Jan 25-126.29%
Jan 25-126.29%
Jan 25-126.29%
Jan 25-126.29%
Jan 25-126.29%
Dec 24-126.29%
Dec 24-126.29%
Dec 24-126.29%
Dec 24-126.29%
Nov 24-126.29%
Nov 24-126.29%
Nov 24-126.29%
Nov 24-97.49%
Nov 24-97.49%
Oct 24-97.49%
Oct 24-97.49%
Oct 24-191.62%
Oct 24-191.62%
Sep 24-201.65%
Sep 24-201.65%
Sep 24-201.65%
Sep 24-201.65%
Aug 24-201.65%
Aug 24-201.65%
Aug 24-201.65%
Aug 24-201.65%
Aug 24-201.65%
Jul 24-201.65%
Price to Sales
02000400060008000med 1058.98Sep 24Jan 25Jul 25Oct 25Feb 26May 26Sep 26
CKDXF Price to Sales by quarter
PeriodPrice to Sales
Sep 26145
Sep 26145
Aug 26145
Aug 26145
Aug 26145
Aug 26145
Jul 26145
Jul 26145
Jul 26145
Jul 26145
Jul 26145
Jun 26145
Jun 26145
Jun 26145
Jun 266380
May 266380
May 266380
May 266380
May 266380
May 266380
Apr 266380
Apr 266380
Apr 266380
Apr 266380
Mar 262938.54
Mar 262938.54
Mar 262938.54
Mar 262938.54
Feb 262938.54
Feb 262938.54
Feb 262938.54
Feb 262938.54
Jan 262938.54
Jan 262938.54
Jan 262938.54
Jan 262938.54
Jan 262938.54
Dec 252938.54
Dec 252938.54
Dec 252938.54
Dec 252938.54
Nov 252938.54
Nov 252938.54
Nov 252938.54
Nov 252938.54
Oct 252938.54
Oct 252938.54
Oct 252938.54
Oct 252938.54
Oct 252938.54
Sep 251058.98
Sep 251058.98
Sep 251058.98
Sep 251058.98
Aug 251058.98
Aug 251058.98
Aug 251058.98
Aug 251058.98
Aug 251058.98
Jul 251058.98
Jul 251058.98
Jul 251058.98
Jul 251058.98
Jun 251058.98
Jun 251058.98
Jun 251058.98
Jun 251058.98
May 251058.98
May 251058.98
Feb 25936.08
Feb 25936.08
Feb 25936.08
Jan 25936.08
Jan 25936.08
Jan 25936.08
Jan 25936.08
Jan 25936.08
Dec 24936.08
Dec 24936.08
Dec 24936.08
Dec 24936.08
Nov 24936.08
Nov 24936.08
Nov 24936.08
Nov 241212.65
Nov 241212.65
Oct 241212.65
Oct 241212.65
Oct 24616.96
Oct 24616.96
Sep 24536.4
Sep 24536.4
Sep 24536.4
Sep 24536.4
Aug 24536.4
Aug 24536.4
Aug 24536.4
Aug 24536.4
Aug 24536.4
Jul 24536.4
Price to Book
0102030med 2.94Jun 22Sep 22Jan 23Apr 23Aug 23May 26Sep 26
CKDXF Price to Book by quarter
PeriodPrice to Book
Sep 260.59
Sep 260.59
Aug 260.59
Aug 260.59
Aug 260.59
Aug 260.59
Jul 260.59
Jul 260.59
Jul 260.59
Jul 260.59
Jul 260.59
Jun 260.59
Jun 260.59
Jun 260.59
Jun 2626.05
May 2626.05
May 2626.05
May 2626.05
May 2626.05
May 2626.05
Apr 2626.05
Apr 2626.05
Apr 2626.05
Apr 2626.05
Sep 232.5
Sep 232.5
Sep 232.5
Sep 232.5
Aug 232.5
Aug 232.5
Aug 232.5
Aug 232.5
Jul 232.5
Jul 232.5
Jul 232.5
Jul 232.5
Jun 232.5
Jun 232.5
Jun 232.5
Jun 232.5
Jun 232.5
May 236.48
May 236.48
May 236.48
May 236.48
Apr 236.48
Apr 236.48
Apr 236.48
Apr 236.48
Mar 236.48
Mar 238
Mar 238
Mar 238
Mar 238
Feb 238
Feb 238
Feb 238
Feb 238
Jan 238
Jan 238
Jan 238
Jan 238
Dec 228
Dec 228
Dec 228
Dec 228
Dec 228
Nov 228
Nov 228
Nov 228
Nov 228
Oct 228
Oct 228
Oct 228
Oct 228
Sep 228
Sep 222.94
Sep 222.94
Sep 222.94
Sep 222.94
Aug 222.94
Aug 222.94
Aug 222.94
Aug 222.94
Jul 222.94
Jul 222.94
Jul 222.94
Jul 222.94
Jul 222.94
Jun 222.94
Jun 222.94
Jun 222.94
Jun 222.94
May 222.94
May 222.94
May 222.94
May 222.94
Apr 222.94
Apr 222.94
Apr 222.94
Ceryvyn Therapeutics Limited
CKDXF
Stockpicker

Video analysis: CKDXF

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.